Public health initiatives focused on obesity prevention and lifestyle intervention programmes
for patients with obesity have struggled to contain the obesity epidemic to date. In recent …

Introduction: Obesity is a rapidly increasing global health problem. The rates of obesity have
tripled over the past three decades and are predicted to rise even further. The need for safe …

The history of anti-obesity pharmacotherapies is marked by disappointments, often
entangled with societal pressure promoting weight loss and the prevailing conviction that …

Available anti-obesity pharmacotherapy options remain very limited. The development of
more effective drugs has become a priority. The potential strategies to achieve weight loss …

Abstract Purpose of Review Obesity is a global health crisis with detrimental effects on all
organ systems leading to worsening disease state and rising costs of care. Persons with …

Obesity is considered a worldwide epidemic. Weight reduction by means of lifestyle changes
is difficult to achieve, and pharmacotherapy is frequently needed. Although all currently …

Abstract Purpose of Review To highlight the added benefits of approved and upcoming,
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …

Obesity is one of the greatest public health challenges of the twenty-first century. The World
Health Organization (WHO) reports that in 2005 approximately 1.6 billion adults were …

The unabated rise in the prevalence of obesity is a challenge for global health care systems.
Efforts to reverse this trend by dietary or behavioral counseling have not been successful …

Obesity is a chronic, relapsing disease that necessitates a multidisciplinary approach to
management. Behavioral changes are the foundation to management, but adjunctive …